1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
TERMINATION OF PREGNANCY WITH VAGINAL ADMINISTRATION OF 16, 16 DIMETHYL PROSTAGLANDIN E2 p-BENZALDEHYDE SEMICARBAZONE ESTER
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1977.tb12540.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 84, Issue 2, pages 135–137, February 1977
Additional Information
How to Cite
Karim, S. M. M. and Ratnam, S. S. (1977), TERMINATION OF PREGNANCY WITH VAGINAL ADMINISTRATION OF 16, 16 DIMETHYL PROSTAGLANDIN E2 p-BENZALDEHYDE SEMICARBAZONE ESTER. BJOG: An International Journal of Obstetrics & Gynaecology, 84: 135–137. doi: 10.1111/j.1471-0528.1977.tb12540.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
A 16, 16 dimethyl prostaglandin E2 p-benzaldehyde semicarbazone ester was used for termination of pregnancy in 54 late first trimester and second trimester patients. The drug (750 μ.g in gelatine glycerine pessaries) was administered every four hours. Fifty patients (92·5 per cent) aborted during the 36 hours treatment. Side effects were mild and consisted of vomiting in five patients, diarrhoea in three patients and transient pyrexia in two.